BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arimont M, Sun SL, Leurs R, Smit M, de Esch IJP, de Graaf C. Structural Analysis of Chemokine Receptor-Ligand Interactions. J Med Chem 2017;60:4735-79. [PMID: 28165741 DOI: 10.1021/acs.jmedchem.6b01309] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 14.2] [Reference Citation Analysis]
Number Citing Articles
1 Kumar N, Acharya V. Machine intelligence-driven framework for optimized hit selection in virtual screening. J Cheminform 2022;14. [DOI: 10.1186/s13321-022-00630-7] [Reference Citation Analysis]
2 Goode-Romero G, Dominguez L. Computational study of the structural ensemble of CC chemokine receptor type 5 (CCR5) and its interactions with different ligands. PLoS One 2022;17:e0275269. [PMID: 36251708 DOI: 10.1371/journal.pone.0275269] [Reference Citation Analysis]
3 Bayrak A, Mohr F, Kolb K, Szpakowska M, Shevchenko E, Dicenta V, Rohlfing AK, Kudolo M, Pantsar T, Günther M, Kaczor AA, Poso A, Chevigné A, Pillaiyar T, Gawaz M, Laufer SA. Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation. J Med Chem 2022. [PMID: 36150079 DOI: 10.1021/acs.jmedchem.2c01198] [Reference Citation Analysis]
4 Bardi G. Chemokines and nanomaterials: interaction for useful immune-applications. Explor Immunol 2022. [DOI: 10.37349/ei.2022.00073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wisniewski S, Dragan P, Makal A, Latek D. Helix 8 in chemotactic receptors of the complement system. PLoS Comput Biol 2022;18:e1009994. [DOI: 10.1371/journal.pcbi.1009994] [Reference Citation Analysis]
6 Lu M, Zhao W, Han S, Lin X, Xu T, Tan Q, Wang M, Yi C, Chu X, Yang W, Zhu Y, Wu B, Zhao Q. Activation of the human chemokine receptor CX3CR1 regulated by cholesterol. Sci Adv 2022;8:eabn8048. [PMID: 35767622 DOI: 10.1126/sciadv.abn8048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Stewart V, Ronald PC. Sulfotyrosine residues: interaction specificity determinants for extracellular protein-protein interactions. Journal of Biological Chemistry 2022. [DOI: 10.1016/j.jbc.2022.102232] [Reference Citation Analysis]
8 Caspar B, Cocchiara P, Melet A, Van Emelen K, Van der Aa A, Milligan G, Herbeuval J. CXCR4 as a novel target in immunology: moving away from typical antagonists. Future Drug Discovery 2022;4. [DOI: 10.4155/fdd-2022-0007] [Reference Citation Analysis]
9 Billen M, Schols D, Verwilst P. Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists. Chem Commun (Camb) 2022;58:4132-48. [PMID: 35274633 DOI: 10.1039/d1cc07080k] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Fang X, Meng Q, Zhang H, Fang X, Huang LS, Zhang X, Schooley RT, Ciechanover A, An J, Xu Y, Huang Z. A fragment integrational approach to GPCR inhibition: Identification of a high affinity small molecule CXCR4 antagonist. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114150] [Reference Citation Analysis]
11 Chen T, Li Y, Sun R, Hu H, Liu Y, Herrmann M, Zhao Y, Muñoz LE. Receptor-Mediated NETosis on Neutrophils. Front Immunol 2021;12:775267. [PMID: 34804066 DOI: 10.3389/fimmu.2021.775267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
12 Stewart V, Ronald PC. Sulfotyrosine, an interaction specificity determinant for extracellular protein-protein interactions.. [DOI: 10.1101/2021.10.29.466493] [Reference Citation Analysis]
13 Grison CM, Lambey P, Jeannot S, Del Nero E, Fontanel S, Peysson F, Heuninck J, Sounier R, Durroux T, Leyrat C, Granier S, Bechara C. Molecular insights into mechanisms of GPCR hijacking by Staphylococcus aureus. Proc Natl Acad Sci U S A 2021;118:e2108856118. [PMID: 34663701 DOI: 10.1073/pnas.2108856118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Luyten K, Van Loy T, Cawthorne C, Deroose CM, Schols D, Bormans G, Cleeren F. D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy. Pharmaceutics 2021;13:1619. [PMID: 34683912 DOI: 10.3390/pharmaceutics13101619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Xu M, Wang Y, Xia R, Wei Y, Wei X. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. Cell Prolif 2021;54:e13115. [PMID: 34464477 DOI: 10.1111/cpr.13115] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
16 Wang Z, Yin X, Ma M, Ge H, Lang B, Sun H, He S, Fu Y, Sun Y, Yu X, Zhang Z, Cui H, Han X, Xu J, Ding H, Chu Z, Shang H, Wu Y, Jiang Y. IP-10 Promotes Latent HIV Infection in Resting Memory CD4+ T Cells via LIMK-Cofilin Pathway. Front Immunol 2021;12:656663. [PMID: 34447368 DOI: 10.3389/fimmu.2021.656663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
17 Hemmatazad H, Berger MD. CCR5 is a potential therapeutic target for cancer. Expert Opin Ther Targets 2021;25:311-27. [PMID: 33719836 DOI: 10.1080/14728222.2021.1902505] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
18 Kharche S, Joshi M, Chattopadhyay A, Sengupta D. Conformational plasticity and dynamic interactions of the N-terminal domain of the chemokine receptor CXCR1. PLoS Comput Biol 2021;17:e1008593. [PMID: 34014914 DOI: 10.1371/journal.pcbi.1008593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
19 Congreve M, Christopher JA, Graaf C. Structure‐Based Drug Design for G Protein‐Coupled Receptors. Burger's Medicinal Chemistry and Drug Discovery 2021. [DOI: 10.1002/0471266949.bmc269] [Reference Citation Analysis]
20 El-Zohairy MA, Zlotos DP, Berger MR, Adwan HH, Mandour YM. Discovery of Novel CCR5 Ligands as Anticolorectal Cancer Agents by Sequential Virtual Screening. ACS Omega 2021;6:10921-35. [PMID: 34056245 DOI: 10.1021/acsomega.1c00681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wu X, Zhang H, Sui Z, Wang Y, Yu Z. The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma. Cancer Biol Med 2021:j. [PMID: 33710803 DOI: 10.20892/j.issn.2095-3941.2020.0140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Shanthamurthy CD, Leviatan Ben-Arye S, Kumar NV, Yehuda S, Amon R, Woods RJ, Padler-Karavani V, Kikkeri R. Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development. J Med Chem 2021;64:3367-80. [PMID: 33683903 DOI: 10.1021/acs.jmedchem.0c01800] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Grison CM, Leyrat C, Lambey P, Jeannot S, Del Nero E, Fontanel S, Peysson F, Heuninck J, Sounier R, Durroux T, Granier S, Bechara C. Mechanisms of GPCR hijacking byStaphylococcus aureus.. [DOI: 10.1101/2021.02.08.430206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Perciani CT, Liu LY, Wood L, MacParland SA. Enhancing Immunity with Nanomedicine: Employing Nanoparticles to Harness the Immune System. ACS Nano 2021;15:7-20. [PMID: 33346646 DOI: 10.1021/acsnano.0c08913] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
25 Kharche S, Joshi M, Chattopadhyay A, Sengupta D. Conformational plasticity and dynamic interactions of the N-terminal domain of the chemokine receptor CXCR1.. [DOI: 10.1101/2020.12.17.423199] [Reference Citation Analysis]
26 Verhaegen Y, Liu L, Nguyen TT, Van Loy T, Voet ARD, Schols D, Dehaen W, De Jonghe S. Palladium-catalyzed cross-coupling reactions on a bromo-naphthalene scaffold in the search for novel human CC chemokine receptor 8 (CCR8) antagonists. Bioorg Chem 2021;107:104560. [PMID: 33383325 DOI: 10.1016/j.bioorg.2020.104560] [Reference Citation Analysis]
27 Işbilir A, Möller J, Arimont M, Bobkov V, Perpiñá-Viciano C, Hoffmann C, Inoue A, Heukers R, de Graaf C, Smit MJ, Annibale P, Lohse MJ. Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists. Proc Natl Acad Sci U S A 2020;117:29144-54. [PMID: 33148803 DOI: 10.1073/pnas.2013319117] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
28 Mensah SA, Nersesyan AA, Ebong EE. Endothelial Glycocalyx-Mediated Intercellular Interactions: Mechanisms and Implications for Atherosclerosis and Cancer Metastasis. Cardiovasc Eng Technol 2021;12:72-90. [PMID: 33000443 DOI: 10.1007/s13239-020-00487-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Tomassi S, Trotta AM, Ieranò C, Merlino F, Messere A, Rea G, Santoro F, Brancaccio D, Carotenuto A, D'amore VM, Di Leva FS, Novellino E, Cosconati S, Marinelli L, Scala S, Di Maro S. Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences. Chem Eur J 2020;26:10113-25. [DOI: 10.1002/chem.202002468] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
30 Soave M, Heukers R, Kellam B, Woolard J, Smit MJ, Briddon SJ, Hill SJ. Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies. Cell Chem Biol 2020;27:1250-1261.e5. [PMID: 32610042 DOI: 10.1016/j.chembiol.2020.06.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
31 Fang X, Meng Q, Zhang H, Liang B, Zhu S, Wang J, Zhang C, Huang LS, Zhang X, Schooley RT, An J, Xu Y, Huang Z. Design, synthesis, and biological characterization of a new class of symmetrical polyamine-based small molecule CXCR4 antagonists. Eur J Med Chem 2020;200:112410. [PMID: 32492596 DOI: 10.1016/j.ejmech.2020.112410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
32 Zhang Y, Liang R, Xie A, Shi W, Huang H, Zhong Y. Antagonistic Peptides That Specifically Bind to the First and Second Extracellular Loops of CCR5 and Anti-IL-23p19 Antibody Reduce Airway Inflammation by Suppressing the IL-23/Th17 Signaling Pathway. Mediators Inflamm 2020;2020:1719467. [PMID: 32410846 DOI: 10.1155/2020/1719467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Soave M, Heukers R, Kellam B, Woolard J, Smit MJ, Briddon SJ, Hill SJ. Monitoring ligand-induced changes in receptor conformation with NanoBiT conjugated nanobodies.. [DOI: 10.1101/2020.04.21.032086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Congreve M, de Graaf C, Swain NA, Tate CG. Impact of GPCR Structures on Drug Discovery. Cell 2020;181:81-91. [DOI: 10.1016/j.cell.2020.03.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 119] [Article Influence: 54.5] [Reference Citation Analysis]
35 Davenport AP, Scully CCG, de Graaf C, Brown AJH, Maguire JJ. Advances in therapeutic peptides targeting G protein-coupled receptors. Nat Rev Drug Discov. 2020;19:389-413. [PMID: 32494050 DOI: 10.1038/s41573-020-0062-z] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 44.5] [Reference Citation Analysis]
36 Oldfield CJ, Duhamel TA, Dhalla NS. Mechanisms for the transition from physiological to pathological cardiac hypertrophy. Can J Physiol Pharmacol 2020;98:74-84. [DOI: 10.1139/cjpp-2019-0566] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 21.5] [Reference Citation Analysis]
37 Gustavsson M. New insights into the structure and function of chemokine receptor:chemokine complexes from an experimental perspective. J Leukoc Biol 2020;107:1115-22. [DOI: 10.1002/jlb.2mr1219-288r] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
38 Miao M, De Clercq E, Li G. Clinical significance of chemokine receptor antagonists. Expert Opin Drug Metab Toxicol 2020;16:11-30. [PMID: 31903790 DOI: 10.1080/17425255.2020.1711884] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 27.5] [Reference Citation Analysis]
39 Wedemeyer MJ, Mueller BK, Bender BJ, Meiler J, Volkman BF. Comparative modeling and docking of chemokine-receptor interactions with Rosetta. Biochem Biophys Res Commun 2020;528:389-97. [PMID: 31924303 DOI: 10.1016/j.bbrc.2019.12.076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Briels B, Graaf C, Bender A. Structural Chemogenomics. Structural Biology in Drug Discovery 2020. [DOI: 10.1002/9781118681121.ch3] [Reference Citation Analysis]
41 Dubyak GR. GPCRs in innate and adaptive immune responses. GPCRs 2020. [DOI: 10.1016/b978-0-12-816228-6.00021-0] [Reference Citation Analysis]
42 Jakowiecki J, Miszta P, Niewieczerzał S, Filipek S. Structural diversity in ligand recognition by GPCRs. GPCRs. Elsevier; 2020. pp. 43-63. [DOI: 10.1016/b978-0-12-816228-6.00003-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Reinecke BA, Wang H, Zhang Y. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors. Curr Top Med Chem 2019;19:2378-92. [PMID: 31833462 DOI: 10.2174/1568026619666191009164609] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
44 Cagliani R, Gatto F, Cibecchini G, Marotta R, Catalano F, Sanchez-Moreno P, Pompa PP, Bardi G. CXCL5 Modified Nanoparticle Surface Improves CXCR2+ Cell Selective Internalization. Cells 2019;9:E56. [PMID: 31878341 DOI: 10.3390/cells9010056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
45 Adlere I, Caspar B, Arimont M, Dekkers S, Visser K, Stuijt J, de Graaf C, Stocks M, Kellam B, Briddon S, Wijtmans M, de Esch I, Hill S, Leurs R. Modulators of CXCR4 and CXCR7/ACKR3 Function. Mol Pharmacol 2019;96:737-52. [DOI: 10.1124/mol.119.117663] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
46 Fox JC, Thomas MA, Dishman AF, Larsen O, Nakayama T, Yoshie O, Rosenkilde MM, Volkman BF. Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1. Sci Signal 2019;12:eaat4128. [PMID: 31481523 DOI: 10.1126/scisignal.aat4128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
47 An Z, Weiss WA. In Vitro Assay to Study Tumor-macrophage Interaction. J Vis Exp 2019. [PMID: 31424440 DOI: 10.3791/59907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Sennikov SV, Alshevskaya AA, Zhukova YV, Belomestnova IA, Karaulov AV, Lopatnikova YA. EXPRESSION DENSITY OF RECEPTORS FOR IMMUNOREGULATORY MEDIATORS AS A MODULATORY COMPONENT OF BIOLOGICAL EFFECTS OF MEDIATORS UPON CELLS (PART 2). Med immunol 2019;21:379-396. [DOI: 10.15789/1563-0625-2019-3-379-396] [Reference Citation Analysis]
49 Arimont M, Hoffmann C, de Graaf C, Leurs R. Chemokine Receptor Crystal Structures: What Can Be Learned from Them? Mol Pharmacol 2019;96:765-77. [PMID: 31266800 DOI: 10.1124/mol.119.117168] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
50 Henrot P, Prevel R, Berger P, Dupin I. Chemokines in COPD: From Implication to Therapeutic Use. Int J Mol Sci 2019;20:E2785. [PMID: 31174392 DOI: 10.3390/ijms20112785] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 15.0] [Reference Citation Analysis]
51 Righetti A, Giulietti M, Šabanović B, Occhipinti G, Principato G, Piva F. CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer? J Oncol 2019;2019:9681698. [PMID: 31275385 DOI: 10.1155/2019/9681698] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
52 Aurelian L, Balan I. GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance. Psychopharmacology (Berl) 2019;236:3023-43. [PMID: 31030249 DOI: 10.1007/s00213-019-05220-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
53 Filipek S. Molecular switches in GPCRs. Current Opinion in Structural Biology 2019;55:114-20. [DOI: 10.1016/j.sbi.2019.03.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
54 Bartekova M, Radosinska J, Jelemensky M, Dhalla NS. Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev 2018;23:733-58. [PMID: 29862462 DOI: 10.1007/s10741-018-9716-x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 99] [Article Influence: 38.7] [Reference Citation Analysis]
55 Apel A, Cheng RK, Tautermann CS, Brauchle M, Huang C, Pautsch A, Hennig M, Nar H, Schnapp G. Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists. Structure 2019;27:427-438.e5. [DOI: 10.1016/j.str.2018.10.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
56 Ghosh S, Bierig T, Lee S, Jana S, Löhle A, Schnapp G, Tautermann CS, Vaidehi N. Engineering Salt Bridge Networks between Transmembrane Helices Confers Thermostability in G-Protein-Coupled Receptors. J Chem Theory Comput 2018;14:6574-85. [PMID: 30359017 DOI: 10.1021/acs.jctc.8b00602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
57 Wedemeyer MJ, Mueller BK, Bender BJ, Meiler J, Volkman BF. Modeling the complete chemokine-receptor interaction. Methods Cell Biol 2019;149:289-314. [PMID: 30616825 DOI: 10.1016/bs.mcb.2018.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
58 Adlere I, Sun S, Zarca A, Roumen L, Gozelle M, Viciano CP, Caspar B, Arimont M, Bebelman JP, Briddon SJ, Hoffmann C, Hill SJ, Smit MJ, Vischer HF, Wijtmans M, de Graaf C, de Esch IJP, Leurs R. Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists. Eur J Med Chem 2019;162:631-49. [PMID: 30476826 DOI: 10.1016/j.ejmech.2018.10.060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
59 Van Hout A, Klarenbeek A, Bobkov V, Doijen J, Arimont M, Zhao C, Heukers R, Rimkunas R, de Graaf C, Verrips T, van der Woning B, de Haard H, Rucker JB, Vermeire K, Handel T, Van Loy T, Smit MJ, Schols D. CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry. Biochem Pharmacol 2018;158:402-12. [PMID: 30342024 DOI: 10.1016/j.bcp.2018.10.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
60 Bowder D, Hollingsead H, Durst K, Hu D, Wei W, Wiggins J, Medjahed H, Finzi A, Sodroski J, Xiang SH. Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses. Virology 2018;521:158-68. [PMID: 29936340 DOI: 10.1016/j.virol.2018.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
61 Miles TF, Spiess K, Jude KM, Tsutsumi N, Burg JS, Ingram JR, Waghray D, Hjorto GM, Larsen O, Ploegh HL, Rosenkilde MM, Garcia KC. Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy. Elife 2018;7:e35850. [PMID: 29882741 DOI: 10.7554/eLife.35850] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
62 Ortiz Zacarías NV, Lenselink EB, IJzerman AP, Handel TM, Heitman LH. Intracellular Receptor Modulation: Novel Approach to Target GPCRs. Trends Pharmacol Sci 2018;39:547-59. [PMID: 29653834 DOI: 10.1016/j.tips.2018.03.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
63 Vass M, Kooistra AJ, Yang D, Stevens RC, Wang MW, de Graaf C. Chemical Diversity in the G Protein-Coupled Receptor Superfamily. Trends Pharmacol Sci 2018;39:494-512. [PMID: 29576399 DOI: 10.1016/j.tips.2018.02.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 14.3] [Reference Citation Analysis]
64 Gahbauer S, Pluhackova K, Böckmann RA. Closely related, yet unique: Distinct homo- and heterodimerization patterns of G protein coupled chemokine receptors and their fine-tuning by cholesterol. PLoS Comput Biol 2018;14:e1006062. [PMID: 29529028 DOI: 10.1371/journal.pcbi.1006062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
65 Brancaccio D, Diana D, Di Maro S, Di Leva FS, Tomassi S, Fattorusso R, Russo L, Scala S, Trotta AM, Portella L, Novellino E, Marinelli L, Carotenuto A. Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)–Ligand Interactions on Living Cancer Cells. J Med Chem 2018;61:2910-23. [DOI: 10.1021/acs.jmedchem.7b01830] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
66 Crawford MA, Margulieux KR, Singh A, Nakamoto RK, Hughes MA. Mechanistic insights and therapeutic opportunities of antimicrobial chemokines. Semin Cell Dev Biol 2019;88:119-28. [PMID: 29432954 DOI: 10.1016/j.semcdb.2018.02.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
67 Lu S, Zhang J. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug–Target Interactions. J Med Chem 2019;62:24-45. [DOI: 10.1021/acs.jmedchem.7b01844] [Cited by in Crossref: 93] [Cited by in F6Publishing: 94] [Article Influence: 23.3] [Reference Citation Analysis]
68 Shah HR, Savjani JK. Recent updates for designing CCR5 antagonists as anti-retroviral agents. Eur J Med Chem 2018;147:115-29. [PMID: 29425816 DOI: 10.1016/j.ejmech.2018.01.085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
69 Pissarek M. Activated Microglia in the Brain: Mitochondrial and Cell Membrane-Associated Targets for Positron Emission Tomography. WJNS 2018;08:50-81. [DOI: 10.4236/wjns.2018.81006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
70 King J, Abraham D, Stratton R. Chemokines in systemic sclerosis. Immunol Lett 2018;195:68-75. [PMID: 29247681 DOI: 10.1016/j.imlet.2017.12.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
71 Di Maro S, Di Leva FS, Trotta AM, Brancaccio D, Portella L, Aurilio M, Tomassi S, Messere A, Sementa D, Lastoria S, Carotenuto A, Novellino E, Scala S, Marinelli L. Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist. J Med Chem 2017;60:9641-52. [DOI: 10.1021/acs.jmedchem.7b01062] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
72 Cavalla F, Biguetti CC, Dionisio TJ, Azevedo MCS, Martins W Jr, Santos CF, Trombone APF, Silva RM, Letra A, Garlet GP. CCR5Δ32 (rs333) polymorphism is associated with decreased risk of chronic and aggressive periodontitis: A case-control analysis based in disease resistance and susceptibility phenotypes. Cytokine 2018;103:142-9. [PMID: 28969941 DOI: 10.1016/j.cyto.2017.09.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
73 Wu F, Song G, de Graaf C, Stevens RC. Structure and Function of Peptide-Binding G Protein-Coupled Receptors. J Mol Biol 2017;429:2726-45. [PMID: 28705763 DOI: 10.1016/j.jmb.2017.06.022] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]